Literature DB >> 1986027

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

J D Veldhuis1, A Iranmanesh, K K Ho, M J Waters, M L Johnson, G Lizarralde.   

Abstract

We have examined the mechanisms underlying reduced circulating GH concentrations in the obese human. Computer-assisted (deconvolution) analysis was used to determine endogenous GH secretory and clearance rates quantitatively from entire 24-h plasma GH concentration profiles. These analyses revealed that the half-life (t 1/2) of endogenous GH was significantly shorter in obese (11.7 +/- 1.6 min) than in normal weight subjects (15.5 +/- 0.81 min; P less than 0.01). The accelerated blood disposal rate of GH was not due to decreased circulating concentrations of GH-binding protein, since the latter were similar in obese (25 +/- 1.0%) and normal weight (24 +/- 2.3%) men. However, obese men had significantly fewer GH secretory bursts (3.2 +/- 0.53 vs. 9.7 +/- 0.67/day; P less than 0.01). Among the rare GH secretory bursts that occurred in obese subjects, there were significantly prolonged mean intersecretory burst intervals (282 +/- 65 vs. 131 +/- 11 min; P less than 0.05). The resultant daily GH production rate in obese men was reduced to one fourth that in normal weight individuals. Both GH secretion rate and burst frequency were negatively correlated with the degree of obesity (ponderal index). The decreases in GH burst frequency and half-life were specific, since GH secretory pulse amplitude (maximal rate of GH release), the mass of GH released per burst, and the duration of computer-resolved GH secretory bursts were not different in obese and normal weight men. We conclude that obese men harbor a double defect in GH dynamics involving both GH secretion and clearance, and that the severity of the GH secretory deficiency is proportionate to the degree of obesity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986027     DOI: 10.1210/jcem-72-1-51

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  85 in total

1.  Secretion of growth hormone releasing hormone in obese children.

Authors:  S Loche; S Balzano; M Bozzola; A Moretta; S Pintus; A Faedda; A Muntoni; D Carta; C Pintor
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

Review 2.  Neuroendocrine control of GH release during acute aerobic exercise.

Authors:  A Weltman; L Wideman; J Y Weltman; J D Veldhuis
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

3.  Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding.

Authors:  Giulia Galli; Aldo Pinchera; Paolo Piaggi; Paola Fierabracci; Monica Giannetti; Giorgia Querci; Giovanni Scartabelli; Luca Manetti; Giovanni Ceccarini; Silvia Martinelli; Claudio Di Salvo; Marco Anselmino; Fausto Bogazzi; Alberto Landi; Paolo Vitti; Margherita Maffei; Ferruccio Santini
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

4.  Absence of ghrelin protects against early-onset obesity.

Authors:  Katherine E Wortley; Juan-Pablo del Rincon; Jane D Murray; Karen Garcia; Keiji Iida; Michael O Thorner; Mark W Sleeman
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

6.  Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.

Authors:  Pamela U Freda; Carlos Reyes-Vidal; Zhezhen Jin; Mya Pugh; Sunil K Panigrahi; Jeffrey N Bruce; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

7.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 8.  The metabolic effects of growth hormone in adipose tissue.

Authors:  Valéria Ernestânia Chaves; Fernando Mesquita Júnior; Gisele Lopes Bertolini
Journal:  Endocrine       Date:  2013-02-21       Impact factor: 3.633

9.  Growth hormone deficiency in patients with obesity.

Authors:  Roberto Salvatori
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

10.  Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.

Authors:  Cristina Maria Mihai; Doina Catrinoiu; Marius Toringhibel; Ramona Mihaela Stoicescu; Negreanu-Pirjol Ticuta; Hancu Anca
Journal:  Cases J       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.